Glenn Davis, in Mililani, HI - Licensed Vocational Nurse

Glenn Davis, is a Licensed Vocational Nurse based in Mililani, Hawaii. Glenn Davis is licensed to practice in California (license number VN 176642) and his current practice location is 95-270 Waikalani Dr, Apt B104, Mililani, Hawaii. He can be reached at his office (for appointments etc.) via phone at (808) 369-5820.

NPI number for Glenn Davis is 1770913642 and his current mailing address is 95-270 Waikalani Dr, Apt B104, Mililani, Hawaii. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1770913642.

Contact Information

	Glenn Davis,
	95-270 Waikalani Dr, Apt B104, Mililani, HI 96789-3527
	(808) 369-5820
	Not Available

Provider's Profile

Full Name	Glenn Davis
Gender	Male
Speciality	Licensed Vocational Nurse
Location	95-270 Waikalani Dr, Mililani, Hawaii
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1770913642
Provider Enumeration Date: 11/13/2013
Last Update Date: 11/13/2013

Medical Identifiers

Medical identifiers for Glenn Davis such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770913642	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	VN 176642 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Glenn Davis is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Glenn Davis, 95-270 Waikalani Dr, Apt B104, Mililani, HI 96789-3527 Ph: (808) 369-5820	Glenn Davis, 95-270 Waikalani Dr, Apt B104, Mililani, HI 96789-3527 Ph: (808) 369-5820

News Archive

Uninsured U.S. residents will spend $30 billion out-of-pocket on health care this year, while receiving $56 billion in uncompensated care

Uninsured U.S. residents will spend about $30 billion out-of-pocket on health care this year, while other parties - mainly the government - will spend about $56 billion on uncompensated care for the uninsured, according to a study published online Monday in the journal Health Affairs, the Wall Street Journal reports.

Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC

Pfizer Inc. announced today that its New Drug Application for crizotinib, an oral first-in-class anaplastic lymphoma kinase inhibitor, has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration and has been filed with the Japanese Ministry of Health, Labour and Welfare.

Brazilian study provides evidence to support effectiveness of Tecta in erosive GERD

Takeda Pharmaceuticals International GmbH announced today results showing pantoprazole magnesium 40 mg (Tecta) was as effective as esomeprazole 40 mg for achieving complete remission (defined as combined endoscopic healing and symptomatic relief) and the mucosal healing rate was high, whilst providing significantly higher symptom relief after 8 weeks.

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

Glenn Davis, - Licensed Vocational Nurse in Mililani, HI